The Philippine Health Insurance Corp. (PhilHealth) continues to provide coverage for its members who have contracted the coronavirus disease 2019 (Covid-19), Cabinet Secretary Karlo Nograles said on Saturday.
“PhilHealth continues to provide financial aid to Covid-19 patients)”, he said
Nograles’ statement came after lawmakers had called for the suspension of PhilHealth’s interim reimbursement mechanism (IRM) program due to issues of alleged favoritisms, inequitable distribution and questionable liquidation.
IRM is an advanced payment scheme that authorizes PhilHealth to give healthcare institutions cash in advance to respond to unanticipated events like natural disasters and calamities.
On Thursday, PhilHealth announced the suspension of IRM to pave the way for a review after the release of payments to hospitals for Covid-19 services had been marred by supposed irregularities.
Nograles said Covid-19 patients need not worry, as PhilHealth will continue to help cover the cost of their treatment despite controversies hounding the state insurance agency.
“We will make sure that PhilHealth will continue to fulfill its mandate, especially now that there is the Covid-19 pandemic,” he said.
PhilHealth pledged to look for ways to make IRM “more responsive to the needs of healthcare facilities affected by the current pandemic to assure patients of continuous access to needed health services.”
The state insurer, nevertheless, ensured that its members can still avail of Covid-19 packages and other benefits.
Under PhilHealth’s case or package rates, around P43,997 will be allotted for Covid-19 patients with mild pneumonia, P143,267 for those with moderate pneumonia, P333,519 for those with severe pneumonia, andP786,384 for those with critical pneumonia.
PhilHealth also shoulders the cost of Covid-19 tests amounting to as high as P8,150.*PNA